DCF Tool

ALGN

Align Technology, Inc. – Surgical Appliance and Supplies Manufacturing
Align Technology designs, manufactures and offers the Invisalign® system, the most advanced clear aligner system in the world, iTero® intraoral scanners and services, and exocad CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 200 thousand doctor customers, and is key to accessing Align's 500 million consumer market opportunity worldwide. Align has helped doctors treat over 9.6 million patients with the Invisalign system and is driving the evolution in digital dentistry through the Align Digital Platform, its integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners.
Analysis Results
Intrinsic Value $248.30
Latest Price $327.48
Relative Value 32% overvalued
Thoughts on this result? Let us know.
Ad
Cash Flow (Millions)
Analysis Parameters
%
%
%
New Ticker
Ad
Analysis Details
Growth Rate Projection

An exponential growth model was fit to the past cash flow data, giving more weight to more recent years. This model determined a growth rate estimate of 15.9%.

Weighted Average Cost of Capital (WACC)

The calculated WACC is 3.4%. This value is used as the default discount rate.

Value of Future Flows

Assuming a growth rate of 15.9%, the cash flows for the next 5 years are projected.

The present value of each year's flow is adjusted to present value using the discount rate.

Year Future flow (million) Present value (million)
2023 377 364
2024 436 408
2025 506 458
2026 587 513
2027 680 576
Terminal Value

Assuming the company was sold after the projection period at an exit multiple of 30, the terminal value of the company would be 20400 million. This corresponds to a present value of 16700 million.

Intrinsic Value Per Share

The total present value of the projected cash flows is 2320 million. Adding in the terminal value gives a total present value of 19000 million.

There are presently 76.6 million outstanding shares, so the intrinsic value per share is 248.3.

Financial Statements

The following data was to determine the past cash flows.

Current Assets 2,424,391,000
Current Cash 999,584,000
Current Liabilities 1,925,887,000
Current Debt 0
Non-Cash Working Capital (NCWC) -501,080,000
Change in NCWC 100,258,000
EBIT 654,048,000
Tax Provision 237,484,000
Depreciation and Amortization 125,793,000
Capital Expenditure -291,900,000
Unlevered Free Cash Flow 328,914,933
Current Assets 2,494,075,000
Current Cash 1,171,342,000
Current Liabilities 1,924,071,000
Current Debt 0
Non-Cash Working Capital (NCWC) -601,338,000
Change in NCWC -164,432,000
EBIT 976,400,000
Tax Provision 240,403,000
Depreciation and Amortization 108,729,000
Capital Expenditure -401,098,000
Unlevered Free Cash Flow 287,749,773
Current Assets 1,849,538,000
Current Cash 960,843,000
Current Liabilities 1,325,601,000
Current Debt 0
Non-Cash Working Capital (NCWC) -436,906,000
Change in NCWC -230,728,000
EBIT 387,171,000
Tax Provision -1,396,939,000
Depreciation and Amortization 93,538,000
Capital Expenditure -154,916,000
Unlevered Free Cash Flow 95,065,000
Current Assets 1,633,419,000
Current Cash 868,627,000
Current Liabilities 970,970,000
Current Debt 0
Non-Cash Working Capital (NCWC) -206,178,000
Change in NCWC -81,225,000
EBIT 506,955,000
Tax Provision 112,347,000
Depreciation and Amortization 78,990,000
Capital Expenditure -149,707,000
Unlevered Free Cash Flow 252,414,344
Current Assets 1,302,479,000
Current Cash 735,359,000
Current Liabilities 692,073,000
Current Debt 0
Non-Cash Working Capital (NCWC) -124,953,000
Change in NCWC -62,598,000
EBIT 457,871,000
Tax Provision 57,723,000
Depreciation and Amortization 54,727,000
Capital Expenditure -223,312,000
Unlevered Free Cash Flow 168,975,965
Current Assets 1,157,003,000
Current Cash 721,542,000
Current Liabilities 497,816,000
Current Debt 0
Non-Cash Working Capital (NCWC) -62,355,000
Change in NCWC -20,742,000
EBIT 350,392,000
Tax Provision 130,162,000
Depreciation and Amortization 37,739,000
Capital Expenditure -195,695,000
Unlevered Free Cash Flow 45,559,469
Current Assets 952,978,000
Current Cash 640,256,000
Current Liabilities 354,335,000
Current Debt 0
Non-Cash Working Capital (NCWC) -41,613,000
Change in NCWC 25,344,000
EBIT 247,237,000
Tax Provision 51,200,000
Depreciation and Amortization 24,002,000
Capital Expenditure -70,576,000
Unlevered Free Cash Flow 173,456,230
Current Assets 732,010,000
Current Cash 527,295,000
Current Liabilities 271,672,000
Current Debt 0
Non-Cash Working Capital (NCWC) -66,957,000
Change in NCWC -67,648,000
EBIT 188,634,000
Tax Provision 42,081,000
Depreciation and Amortization 18,004,000
Capital Expenditure -53,451,000
Unlevered Free Cash Flow 42,885,240
Current Assets 657,160,000
Current Cash 454,658,000
Current Liabilities 201,811,000
Current Debt 0
Non-Cash Working Capital (NCWC) 691,000
Change in NCWC 1,346,000
EBIT 193,576,000
Tax Provision 44,537,000
Depreciation and Amortization 17,856,000
Capital Expenditure -24,092,000
Unlevered Free Cash Flow 143,398,719
Current Assets 544,676,000
Current Cash 369,993,000
Current Liabilities 175,338,000
Current Debt 0
Non-Cash Working Capital (NCWC) -655,000
Change in NCWC 4,194,000
EBIT 161,225,000
Tax Provision 28,844,000
Depreciation and Amortization 16,825,000
Capital Expenditure -19,412,000
Unlevered Free Cash Flow 112,902,605
Current Assets 485,793,000
Current Cash 334,871,000
Current Liabilities 155,771,000
Current Debt 0
Non-Cash Working Capital (NCWC) -4,849,000
Change in NCWC 6,522,000
EBIT 122,183,000
Tax Provision 25,605,000
Depreciation and Amortization 17,811,000
Capital Expenditure -38,333,000
Unlevered Free Cash Flow 71,069,783

This analysis is provided for informational purposes only and does not constitute financial or investing advice. For more information on the advantages and limitations of DCF analysis see background. This information is provided on an "as is" basis. No warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information. By using this site you agree that under no circumstances shall Valuation Tools LLC be held liable for any loss or damage caused by information obtained from this website including any articles, data, videos, its social media accounts, or any other materials.